Services Biology Immunology & Inflammation
Immunology & Inflammation
Over 100 validated in vivo models supporting immunology and inflammation research across autoimmune, gastrointestinal, dermatological, neurological, and inflammatory diseases.
BioDuro provides in vivo pharmacology services that help researchers evaluate therapeutic activity and investigate disease biology using established models of rheumatoid arthritis, lupus, inflammatory bowel disease, dermatitis, multiple sclerosis, and other immune-mediated disorders.
Immunology & Inflammation Capabilities
BioDuro offers a broad portfolio of validated in vivo models supporting the evaluation of therapeutic candidates across autoimmune, inflammatory, and immune-mediated diseases.
Autoimmune Diseases
Validated models supporting the study of immune dysregulation, disease progression, and therapeutic efficacy across autoimmune disorders.
- Rheumatoid Arthritis (CIA, AIA, CAIA)
- Systemic Lupus Erythematosus (SLE)
- Multiple Sclerosis (EAE)
- Graft-versus-Host Disease (GvHD)
Inflammatory & Dermatological Diseases
Disease models designed to investigate inflammatory pathways and evaluate novel therapies targeting skin and systemic inflammation.
- Dermatitis
- Psoriasis
- Urticaria
- Hidradenitis Suppurativa
Gastrointestinal & Inflammatory Diseases
Disease models designed to investigate inflammatory pathways and evaluate novel therapies targeting skin and systemic inflammation.
- Colitis / Inflammatory Bowel Disease (IBD)
- Pancreatitis
- Acute Inflammation Models
- Neuroinflammation Models
Supporting Immunology & Inflammation Research
BioDuro’s in vivo pharmacology capabilities support the evaluation of novel therapies across a broad range of immune-mediated and inflammatory diseases, helping researchers generate efficacy and disease biology data throughout discovery programs.
Therapeutic Efficacy Evaluation
Assess the impact of therapeutic candidates using validated disease models that measure clinically relevant endpoints and biological responses.
Disease Mechanism Investigation
Study disease progression and immune-mediated pathways to better understand target biology and therapeutic mechanisms.
Biomarker & Translational Studies
Generate biological data that support the evaluation of treatment response and disease modulation.
Candidate Selection
Support data-driven decision-making through integrated pharmacology studies that help prioritize promising therapeutic candidates.
Frequently Asked Questions
About immunology and inflammation
BioDuro provides more than 100 validated in vivo models supporting immunology and inflammation research, including models for rheumatoid arthritis, lupus, inflammatory bowel disease (IBD), dermatitis, psoriasis, multiple sclerosis, graft-versus-host disease (GvHD), and other immune-mediated disorders.
Immunology and inflammation models help researchers evaluate therapeutic efficacy, investigate disease mechanisms, and assess biological responses in relevant disease settings before advancing development programs.
Yes. BioDuro supports autoimmune disease research through validated models of rheumatoid arthritis, systemic lupus erythematosus (SLE), multiple sclerosis (EAE), and other immune-mediated disorders.
BioDuro utilizes validated disease models and pharmacology endpoints to assess treatment responses, disease progression, and biological activity across a broad range of immunology and inflammation programs.
Related Resources
Explore BioDuro’s immunology and inflammation whitepaper to learn how our integrated in vitro assays and validated in vivo disease models support therapeutic discovery and preclinical research across autoimmune and inflammatory diseases.
Related Biology Services
Immunology and inflammation studies are often integrated with complementary biology services to investigate disease mechanisms, evaluate therapeutic candidates, and generate translational insights across discovery programs.